论文信息 - Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age‐related macular degeneration

Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age‐related macular degeneration

Intravitreal triamcinolone has been suggested as an adjunctive to photodynamic therapy in the treatment of exudative macular degeneration. One of the side‐effects of intravitreal triamcinolone is the development of cataract, and it is known that cataract extraction can exacerbate macular degeneration. A case is presented where combined intravitreal triamcinolone and photodynamic therapy stopped the progression of the exudative macular degeneration. Subsequent progression of cataract required cataract extraction, which resulted in a very rapid progression of the exudative macular degeneration and loss of vision.

M. Gillies | J. Larsson

[1] R P Danis,et al. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration , 2004, British Journal of Ophthalmology.

[2] P. Mitchell,et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. , 2004, Archives of ophthalmology.

[3] R. Klein,et al. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. , 2003, Ophthalmology.

[4] B. Munoz,et al. Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. , 2003, American journal of ophthalmology.

[5] J. Sorenson,et al. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. , 2003, Ophthalmology.